Cascade Financial Partners LLC Sells 24,000 Shares of Revvity Inc. $RVTY

Cascade Financial Partners LLC reduced its holdings in Revvity Inc. (NYSE:RVTY) by 12.9% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 162,671 shares of the company’s stock after selling 24,000 shares during the quarter. Revvity accounts for about 1.5% of Cascade Financial Partners LLC’s investment portfolio, making the stock its 11th largest holding. Cascade Financial Partners LLC’s holdings in Revvity were worth $15,738,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. CYBER HORNET ETFs LLC bought a new stake in shares of Revvity in the second quarter worth about $32,000. Cromwell Holdings LLC increased its holdings in shares of Revvity by 141.4% in the fourth quarter. Cromwell Holdings LLC now owns 338 shares of the company’s stock worth $33,000 after acquiring an additional 198 shares in the last quarter. MUFG Securities EMEA plc bought a new stake in shares of Revvity in the second quarter worth about $34,000. Headlands Technologies LLC bought a new stake in shares of Revvity in the second quarter worth about $49,000. Finally, Smartleaf Asset Management LLC increased its holdings in shares of Revvity by 56.8% in the third quarter. Smartleaf Asset Management LLC now owns 690 shares of the company’s stock worth $58,000 after acquiring an additional 250 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors.

Revvity Stock Up 0.2%

NYSE:RVTY opened at $94.19 on Monday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The company has a market cap of $10.51 billion, a PE ratio of 45.07, a PEG ratio of 2.02 and a beta of 1.05. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $118.30. The stock has a 50-day simple moving average of $90.31 and a 200 day simple moving average of $96.92.

Revvity (NYSE:RVTY) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.04. The business had revenue of $711.12 million during the quarter, compared to the consensus estimate of $704.07 million. Revvity had a return on equity of 8.00% and a net margin of 8.26%.Revvity’s quarterly revenue was up 7.0% on a year-over-year basis. During the same period last year, the company earned $1.01 earnings per share. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. On average, sell-side analysts expect that Revvity Inc. will post 5.33 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Investors of record on Friday, July 17th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, July 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 13.40%.

Analyst Ratings Changes

Several equities research analysts have issued reports on the company. Stifel Nicolaus lowered their price target on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Wells Fargo & Company increased their price target on Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 3rd. The Goldman Sachs Group lowered their price target on Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a report on Tuesday, April 14th. TD Cowen increased their price target on Revvity from $115.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Finally, Barclays increased their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Four equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Revvity currently has a consensus rating of “Hold” and an average price target of $107.73.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.